Loading clinical trials...
Loading clinical trials...
Effectiveness of Sofosbuvir/Pegylated-interferon Plus Ribavirin in Treatment of Hepatitis C Virus Genotype 4 Patients
Conditions
Interventions
SOF/RBV/PegINFα-2
Start Date
March 1, 2015
Primary Completion Date
November 1, 2015
Completion Date
November 1, 2015
Last Updated
May 11, 2020
NCT06718530
NCT05361603
NCT05975216
NCT05071261
NCT05906459
NCT04980157
Lead Sponsor
Beni-Suef University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions